MMSI vs PATH · P/E 28, rev $1.36B vs P/E 19, rev $1.61B
Merit Medical Systems Inc (MMSI) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Merit Medical Systems Inc (MMSI) is a medical instruments & supplies company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported MMSI revenue for 2024-12-31 was $1.36B. Net income was $120.4M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. MMSI currently screens at market cap $3.89B and trailing P/E 28.1.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
MMSI currently screens at market cap $3.89B and trailing P/E 28.1. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the MMSI and PATH stock pages for the full models.
Not investment advice.